Anidulafungin: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
==Category== | ==Category== | ||
Antifungal | |||
==US Brand Names== | ==US Brand Names== | ||
| Line 22: | Line 22: | ||
'''| [[Anidulafungin drug interactions|Drug Interactions]]''' | '''| [[Anidulafungin drug interactions|Drug Interactions]]''' | ||
'''| [[Anidulafungin overdosage|Overdosage]]''' | '''| [[Anidulafungin overdosage|Overdosage]]''' | ||
'''| [[Anidulafungin how supplied|How Supplied]]''' | '''| [[Anidulafungin how supplied|How Supplied]]''' | ||
'''| [[Anidulafungin labels and packages|Labels and Packages]]''' | '''| [[Anidulafungin labels and packages|Labels and Packages]]''' | ||
Revision as of 12:02, 9 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Category
Antifungal
US Brand Names
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | How Supplied | Labels and Packages